Eisai, Biogen move Alzheimer’s treatment into Phase III

26th March 2019 Uncategorised 0

Eisai and Biogen’s BAN2401 is to be put into Phase III trial for patients with early Alzheimer’s disease.

More: Eisai, Biogen move Alzheimer’s treatment into Phase III
Source: News